BRODALUMAB Is A Monoclonal Antibody. It Is Used To Treat psoriasis.Brodalumab Is A Human Monoclonal Antibody Designed For The Treatment Of Inflammatory Diseases. In February 2017 It Received US FDA Approval To Treat Moderate To Severe Plaque Psoriasis In People Who Have Not Improved With Other Treatments